(Date:12/2/2009)... Martek Biosciences Corporation (Nasdaq: MATK ) announced today ... quarter and fiscal year 2009 on December 16, 2009, at ... at 4:45 p.m. ET Martek will conduct a conference call ... may listen to the call live via webcast by visiting ...
(Date:12/2/2009)... YORK, Dec. 2 Nearly 600 medical research executives, ... novel development approaches and innovative funding strategies at the ... FasterCures, the Washington-based center of the Milken ... multi-sector collaborations needed to turn a scientific discovery into ...
(Date:12/2/2009)... Holding NV,the Netherlands based biotechnology company focusing on protein ... that it,has appointed Wim E.M. Mol, Ph.D. as new ... Mol will be responsible for all of Pepscans corporate ... company. He brings to,Pepscan more than 20 years of ...
(Date:12/2/2009)... Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,("Simcere" or ... leading pharmaceutical company,specializing in the development, manufacturing, and ... today announced that 105 of,its drugs have been ... was issued by China,s Ministry of Human Resources ...
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Dutch Biotech Company Pepscan Appoints New CEO 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3(Date:12/4/2009)... Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today ... the company,s Phase II-b, dose escalation, clinical trial in ... injury (TBI). Oxycyte is the Company,s perfluorocarbon (PFC) therapeutic ... in improving the outcome of patients with severe TBI. ...
(Date:12/4/2009)... Chemistry World recently highlighted a new ... of America ( PhRMA ) that identifies 97 new ... ,, The report found that the 97 products ... are either in human clinical trials or awaiting approval by ...
(Date:12/4/2009)... DIEGO, Calif., Dec. 4 Suneva Medical, a privately-held ... Philip Ranker as Vice President and Chief Financial Officer. ... Suneva Medical,s general and administrative functions including finance, accounting, ... also serve on the Company,s senior management team. ...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Zix Corporation CEO Provides Corporate Update for Second Quarter 2009 51001 1Zix Corporation CEO Provides Corporate Update for Second Quarter 2009 51001 2Zix Corporation CEO Provides Corporate Update for Second Quarter 2009 51001 3Zix Corporation CEO Provides Corporate Update for Second Quarter 2009 51001 4Spa Chefs Prepare You for a Healthy Summer 50996 1Spa Chefs Prepare You for a Healthy Summer 50996 2New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 12927 1New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 12927 2New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 12927 3New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 12927 4New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 12927 5New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 12927 6